- Home
- ELVN vs PUMP Comparison
ELVN vs PUMP Comparison
Compare ELVN & PUMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- PUMP
- Stock Information
- Founded
- ELVN 2016
- PUMP 2007
- Country
- ELVN United States
- PUMP United States
- Employees
- ELVN N/A
- PUMP N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- PUMP Oilfield Services/Equipment
- Sector
- ELVN Health Care
- PUMP Energy
- Exchange
- ELVN Nasdaq
- PUMP Nasdaq
- Market Cap
- ELVN 1.1B
- PUMP 870.7M
- IPO Year
- ELVN 2020
- PUMP 2017
- Fundamental
- Price
- ELVN $21.00
- PUMP $7.30
- Analyst Decision
- ELVN Strong Buy
- PUMP Buy
- Analyst Count
- ELVN 5
- PUMP 7
- Target Price
- ELVN $37.80
- PUMP $11.17
- AVG Volume (30 Days)
- ELVN 213.5K
- PUMP 1.9M
- Earning Date
- ELVN 03-17-2025
- PUMP 04-30-2025
- Dividend Yield
- ELVN N/A
- PUMP N/A
- EPS Growth
- ELVN N/A
- PUMP N/A
- EPS
- ELVN N/A
- PUMP N/A
- Revenue
- ELVN N/A
- PUMP $1,444,286,000.00
- Revenue This Year
- ELVN N/A
- PUMP $0.05
- Revenue Next Year
- ELVN N/A
- PUMP $6.99
- P/E Ratio
- ELVN N/A
- PUMP N/A
- Revenue Growth
- ELVN N/A
- PUMP N/A
- 52 Week Low
- ELVN $10.90
- PUMP $6.54
- 52 Week High
- ELVN $30.03
- PUMP $11.17
- Technical
- Relative Strength Index (RSI)
- ELVN 47.82
- PUMP 27.65
- Support Level
- ELVN $18.67
- PUMP $7.11
- Resistance Level
- ELVN $22.36
- PUMP $8.47
- Average True Range (ATR)
- ELVN 1.07
- PUMP 0.43
- MACD
- ELVN 0.06
- PUMP -0.14
- Stochastic Oscillator
- ELVN 60.84
- PUMP 13.03
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.
About PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.